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Warm-blood cardioplegic arrest induces selective mitochondrial
translocation of protein kinase Ce followed by interaction with 6.1
inwardly rectifying potassium channel subunit in viable myocytes
overexpressing urocortin
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Objective: This study investigates the cardioprotective role and mechanism of action of urocortin in patients un-
dergoing cardiac surgery, with respect to protein kinase Ce expression, activation, and relocation.
Background: Cardioplegic arrest and subsequent reperfusion inevitably expose the heart to iatrogenic ischemia/
reperfusion injury. We previously reported that iatrogenic ischemia/reperfusion injury caused myocyte induction
of urocortin, an endogenous cardioprotective peptide.
Methods: Two sequential biopsies were obtained from the right atrium of 25 patients undergoing coronary artery
bypass grafting at the start of grafting (internal control) and 10 minutes after release of the aortic clamp.
Results: In hearts exposed to iatrogenic ischemia/reperfusion injury, induction of urocortin was documented at
both the mRNA (255% of basic levels; P< .05) and the protein (4-fold increase; P< .01) levels. Iatrogenic is-
chemia/reperfusion injury also induced a selective increase of protein kinase Ce mRNA (225% of internal con-
trol; P<.05) and a 2-fold overexpression of total protein kinase Ce (P<.05), which paralleled a 2.9-fold increase
in protein kinase Ce phosphorylation (P< .01). Mitochondrial translocation of activated protein kinase Ce was
observed only in postcardioplegic samples, using both subcellular fractionation (P< .05) and immunostaining
techniques (P<.05). Enhanced protein kinase Ce/mitochondria colocalization was selectively observed in viable
myocytes, showing concurrently positive staining for urocortin (P<.05). Finally, co immunoprecipitation exper-
iments documented an iatrogenic ischemia/reperfusion injury-enhanced physical interaction of phosphorylated
protein kinase Ce with the 6.1 inwardly rectifying potassium channel subunit of the KATP channels (P< .05).
Conclusion:After iatrogenic ischemia/reperfusion injury, urocortin expression in viable cells selectively colocal-
ized with enhanced phosphorylation andmitochondrial relocation of protein kinase Ce, suggesting a cardioprotec-
tive role for endogenous urocortin. The physical interaction of activated protein kinase Ce with 6.1 inwardly
rectifying potassium channel, enhanced by cardioplegic arrest, may represent a conjectural mechanism of urocor-
tin-mediated cardioprotection.
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SCardioplegic arrest and subsequent reperfusion expose the
human heart undergoing on-pump cardiac surgery to mild
forms of ischemia/reperfusion (I/R) injury. These controlled
forms of surgical cardiac arrest are likely to represent, to-
gether with the short coronary occlusions induced by bal-
loon inflation during percutaneous transluminal coronary
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chemia/reperfusion injury (iIRI). Several cardioplegic
techniques, such as crystalloid, cold, and warm-blood cardi-
oplegia, have been developed in the attempt to prevent or at
least to reduce to a minimum this inevitable surgically
related ischemic insult.1 Route and modality administration
of cardioplegia (continuous vs intermittent; antegrade vs ret-
rograde) have also been extensively modified and diversified
to maximize the final degree of cardioprotection during car-
diac surgery. Nonetheless, the protection afforded by the dif-
ferent techniques used so far was shown to be oftentimes
inadequate, above all when case-related technical difficulties
considerably prolong the overall time during which the heart
is maintained on cardiopulmonary bypass.2-4
Apoptotic cell death has been extensively implicated in
the pathogenesis of I/R injury, including the iatrogenic var-
iants associated with on-pump cardiac surgery. DNA frag-
mentation has been detected by terminal deoxynucleotidylrdiovascular Surgery c Volume 138, Number 5 1213
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SAbbreviations and Acronyms
ATP ¼ adenosine-50-triphosphate
CABG ¼ coronary artery bypass graft
Hsp ¼ heat shock protein
iIRI ¼ iatrogenic ischemia/reperfusion
injury
I/R ¼ ischemia/reperfusion
Kir6.1 ¼ 6.1 inwardly rectifying potassium
channel
Kir6.2 ¼ 6.2 inwardly rectifying potassium
channel
PCR ¼ polymerase chain reaction
PKC ¼ protein kinase C
SDS-PAGE ¼ sodium dodecyl sulfate-
polyacrylamide gel electrophoresis
SUR ¼ sulfonylurea receptor
TUNEL ¼ terminal deoxynucleotidyl
transferase-mediated nick
end labeling
Ucn ¼ urocortin
transferase-mediated nick end labeling (TUNEL) staining in
atrial biopsies from patients protected by 3 different cold an-
tegrade crystalloid cardioplegic solutions (St Thomas II
[Ko¨hler Chemie, Alsbach, Germany], Bretschneider [Ko¨hler
Chemie], or Hamburg [Fresenius AG, Bad Homburg, Ger-
many]), as well as by cold-blood cardioplegia.5,6 The occur-
rence of apoptosis has also been evaluated and quantified by
our group in the human heart from patients exposed to warm-
blood cardioplegic arrest and subsequent reperfusion.7 On
the basis of our findings, warm-blood cardioplegia was in-
deed associated with myocyte apoptosis, but also with in-
creased expression of urocortin (Ucn), a 40-amino acid
cardioprotective peptide, member of the corticotropin releas-
ing factorfamily.7 Myocytes overexpressing Ucn never ex-
hibited TUNEL-positive staining, providing evidence that
endogenous Ucn effectively protects those myocytes in
which it is produced.7 In addition, viable myocytes overex-
pressing Ucn showed concurrent overexpression of the 6.1
inwardly rectifying potassium channel (Kir6.1) subunit of
the adenosine-50-triphosphate (ATP)-sensitive inwardly rec-
tifying potassium (KATP) channel. These data are in line
with previous experimental findings showing that administra-
tion of exogenous Ucn to a rat model of I/R injury induced
overexpression of the Kir6.1 cardiac KATP channel subunit,
without having any effect on the other 2 channel subunits,
namely, 6.2 inwardly rectifying potassium channel (Kir6.2)
and sulfonylurea receptor (SUR)-2.8 The KATP channel is
closed under normal conditions and functions as a sensitive
sensor of the metabolic state of the cell.9 Opening of the
cardiac KATP channel, which is triggered by a decrease in1214 The Journal of Thoracic and Cardiovascular Suintracellular ATP concentration, was shown to exert cardio-
protective effects in numerous studies.10,11 The signaling
pathways leading to activation and opening of theKATP chan-
nels are still under investigation. Protein kinase G was shown
to transmit the cardioprotective signal to the KATP channels
through a protein kinase C (PKC)-dependent pathway,12
but it is still unclear how this signal is transmitted and which
isoforms of PKC are involved in this process.
Recent works have increasingly identified in PKCe the
PKC isoform chiefly involved in mediating cardioprotection
against I/R injury and producing the phenomenon of ische-
mic preconditioning.13,14 Exogenous Ucn was shown to
cause activation and mitochondrial translocation of PKCe,
whereas pharmacologic inhibition of PKCe and knockout
of the PKCe gene both resulted in abrogation of Ucn’s car-
dioprotective effects,15 suggesting that Ucn-mediated cardi-
oprotection is dependent on PKCe activation.
Despite the redundancy of experimental data, the exis-
tence of a Ucn-activated cardioprotective pathway acting
on the myocyte mitochondrion was never investigated in
the human heart.
Thus, this study aimed to investigate the following in the
human heart exposed to warm-blood cardioplegic arrest and
subsequent reperfusion: (1) the changes in expression, acti-
vation, and subcellular localization of PKCe induced by en-
dogenous Ucn; (2) the existence of specific mitochondrial
partners interacting with PKCe; and (3) the role played by
the above changes in Ucn-mediated cardioprotection.
MATERIALS AND METHODS
Patient Population
The study was approved by the institutional ethics committee of the Uni-
versity of Verona, and all patients selected gave informed consent before
enrollment. Twenty-five patients (11 female and 14 male) admitted for elec-
tive on-pump coronary artery bypass graft (CABG) surgery, were recruited.
All patients had multiple-vessel coronary disease with symptoms of class II/
III, according to the Canadian Cardiovascular Society Angina Classification.
Exclusion criteria were (1) symptoms of angina pectoris or heart failure dur-
ing the week preceding the operation; (2) reduced left ventricular ejection
fraction (<40%); (3) enlargement or hypertrophy of ventricular or atrial car-
diac chambers; d) concomitant valvular disease; (4) arrhythmias; (5) diabetes
and other metabolic disorders; and (6) concomitant liver, pulmonary, or kid-
ney diseases. The intentional enrollment of subjects who were otherwise
healthy, unlike the patient population typically undergoing CABG surgery,
although representing a limitation of our study, also has the merit of restrict-
ing the degree of interference that comorbidities might have exerted. In addi-
tion, another study comparing the effects of cardioplegic arrest in diabetic
versus nondiabetic patients is currently being carried out by our group.
All patients were receiving calcium channel blockers and b-blockers,
which were discontinued, together with all other medications, 2 days before
surgery.
Surgical Procedure
Cardiopulmonary bypass was conducted with nonpulsatile flow at a rate
of 2.4 L/min/m2. After aortic crossclamping, intermittent antegrade and ret-
rograde warm-blood cardioplegia was initiated through the infusion of
whole blood plus 20 mEq/L of Kþ. The cardioplegic solution was injected
at 37C for 2 minutes into the aortic root (flow rate, 300 mL/min) and forrgery c November 2009
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San additional 2 minutes into the coronary sinus at approximately 150 mL/
min (40 mm Hg). This dose of cardioplegic solution was infused every
15 to 20 minutes via antegrade and retrograde injection. After completion
of the distal anastomoses, the aortic crossclamp was removed and the con-
struction of the proximal anastomoses was begun. At the end of the grafting
procedure, protamine (3 mg/kg) was injected to reverse the effect of heparin.
Inotropic drugs were not used.
Tissue Sampling and Preparation
Our histologic andmolecular evaluations have been carried out in bioptic
tissues from the right atrium, whose changes during cardioplegic arrest and
subsequent may not fully reflect those occurring in ventricular myocytes.
Two sequential biopsies were obtained from a virgin site in the right
atrium by 2 highly experienced cardiac surgeons (G.F. and A.M.). The first
biopsy was taken as a control sample before starting cardiopulmonary
bypass. The second was obtained as close as possible to the site of the pre-
vious sampling approximately 10 minutes after the release of the aortic
crossclamp. There were no clinical complications related to the sampling
procedure. Immediately after collection, each atrial biopsy was cut into 3
parts. The first portion was fixed in 4% formaldehyde, stored at 4C for
a maximum of 48 hours, subsequently wax embedded, and finally used
for immunofluorescent staining. The second portion was stored at 4C in
RNAlater Solution (Ambion, Austin, Tex) and subsequently used for
RNA isolation. The third portion, immediately after collection, was parceled
out into 3 fragments, 2 of which were collected into separate cryovials, snap-
frozen in liquid nitrogen, stored at80C, and finally used for protein iso-
lation from total tissue extracts. The third and final fragment was collected
into ice-cold phosphate-buffered saline and immediately used for isolation
of mitochondrial and cytoplasmic fractions (see below). To obtain adequate
amounts of proteins, pre- and postcardioplegic samples collected from
batches of 3 different patients (with the exception of 1 batch composed of
4) were combined and processed together.
RNA Isolation and Quantitative Polymerase Chain
Reaction
Total RNA was isolated from cardiac samples by using an RNA isolator
solution TRIzol (Gibco-BRL, Sussex, United Kingdom), treated with DN-
Ase (Promega, Madison, WI) and subsequently reversed transcribed with
Superscript II reverse transcriptase (Gibco BRL) and oligodT (18mer)
primer.16 Real-time, 1-step polymerase chain reaction (PCR) for specific
mRNA was performed using the QuantiTect SYBR Green PCR Kit (Qia-
gen, Venlo, The Netherlands) and LightCycler 1.5 Instrument (Roche Diag-
nostics, Indianapolis, IN), according to the manufacturer’s instructions. The
following specific primers were used to quantitate by qPCR the transcript
levels of the genes of interest. Ucn primer sequences were 50-GCT
TGCTGGTGAAAAGGACC-30 (sense) and 50-CTTGCCCACCGAGTCG
AAT-30 (antisense). PKCe primer sequences were 50-ACCAAGCAGAAG
ACCAACAG-30 (sense) and 50-TTCCTATGACACCCCAGATG-30
(antisense).
Immunoblotting Material and Approach
Types and sources of the antibody used for the immunoblotting proce-
dure are as follows: The antibody against actin, heat shock protein
(Hsp)60, total PKCe, Kir6.1 (H80), Kir6.2 (H55), and SUR-2 (H80) were
obtained from Santa Cruz Biotechnology (Santa Cruz, Calif). The anti-
phospho-PKCe (Ser729) rabbit polyclonal antibody was purchased from
Upstate Biotechnology (Lake Placid, NY). All secondary antibodies were
conjugated to horseradish peroxidase and the ensuing immunoreactive
bands were developed using a Western Lightning Chemiluminescence kit
(PerkinElmer Life Science, Boston, Mass). The nitrocellulose membrane
used for Western blotting was obtained from Bio-Rad Laboratories (Hercu-
les, Calif). Immunoblots were digitalized and quantified using ImageJ soft-
ware (National Institutes of Health, Bethesda, Md).The Journal of Thoracic and CaWestern Blotting
Pre- and postcardioplegic cardiac specimens were homogenized in lysis
buffer (100 mmol/L NaCl, 0.1% Triton X-100, 50 mmol/L Tris; pH: 8.3)
loaded on 8% sodium dodecyl sulfate (SDS)-polyacrylamide gel, separated
by gel electrophoresis, transferred onto a nitrocellulose membrane, and
probed with relevant primary antibody. For the specific assessment of
Ucn protein, whose molecular weight is 4693.52 dalton, we used a tricine
SDS-polyacrylamide gel electrophoresis (PAGE) system, composed of
16% T and 6% C, where T indicates the total percentage concentration
of both monomers (acrylamide and the crosslinker bisacrylamide) and C in-
dicates the percentage concentration of the crosslinker relative to the total
concentration.17 The SDS-PAGE system was enriched with 6 mol/L urea
to reduce the electrophoretic mobility of small proteins, with subsequent en-
hanced resolution of peptides having a molecular weight less than 5 kDa.
Mitochondrial and Cytoplasmic Protein
Fractionation, Characterization, and Assessment
Mitochondrial and cytosolic fractions were prepared using a commer-
cially available kit (Mitochondria Isolation Kit for Tissue; Pierce Protein
Research Products, Thermo Fisher Scientific, Rockford, Ill), according to
the manufacturer’s instructions. Equal amounts (20 mg) of cytoplasmic
and mitochondrial proteins were separated using SDS-PAGE, as previously
described,18,19 and subsequently probed with antibody against total and
phosphorylated PKCe, Kir6.1, Kir6.2, and SUR-2. Hsp60 and actin anti-
body were used to probe for mitochondrial and cytoplasmic fractions, re-
spectively.
Co-immunoprecipitation
After homogenization of the myocardial tissues in lysis buffer, phos-
phorylated PKCe was enriched by immunoprecipitation overnight at 4C
and subsequently immunoblotted with Kir6.1, Kir6.2, or SUR-2 antibody,
as previously described.20 Western blotting was performed following stan-
dard protocols with equal amounts of protein loaded for each sample.
Immunocytochemistry Assessment
Serial 5-mm myocardial sections were stained with antibody against
phosphorylated PKCe and Hsp60 (used as a specific marker of mitochon-
dria), and subsequently counterstained with TOPRO-3. In another set of
staining reactions, adjacent 5-mm myocardial sections were serially cut
from the same wax blocks, stained with TUNEL reagents or an antibody
against Ucn, counterstained with propidium iodide, and finally incubated
with suitable secondary antibodies (DakoCytomation, Glostrup, Denmark),
as previously described.7,19,21 To assess the mitochondrial relocation of
activated PKCe, the phosphorylated active form of PKCe and the mitochon-
dria were labeled with specific primary antibody and visualized by incuba-
tion with secondary antibody conjugated with fluorescein and rhodamine,
respectively. The percentage of colocalization of phosphorylated PKCe
and mitochondria was digitally quantified by means of image analyzer soft-
ware in myocardial sections from samples collected before and after cardi-
oplegic arrest. Sections were analyzed by a confocal microscopist (T.M.S.)
who was blinded to the origin and sequence of the specimens. Data were ex-
pressed as the means of 12 to 15 high-power fields ( standard deviation).
Statistical Analysis
Significance was evaluated using the 2-tailed analysis of variance.
RESULTS
Patient Characteristics
Operative details and clinical characteristics of the enrolled
patients are summarized in Table 1. All subjects were white
and aged between 51 and 78 years (mean, 63  5 years)rdiovascular Surgery c Volume 138, Number 5 1215
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Swith multiple-vessel coronary disease and symptoms of class
II/III, according to the Canadian Cardiovascular Society
Angina Classification. As previously stated, the intentional
recruitment of patients without significant comorbidities,
although introducing a limitation in our study, has the advan-
tage of minimizing the concurrence of unknown confounding
factors intrinsic to diverse pathologic conditions. All patients
electively underwent multiple CABGs with internal thoracic
arteries and saphenous veins.Mean values of pre- and postop-
erative ejection fractionwere 54 1 and 52 3, respectively.
In no case was catecholamine support required. Aortic cross-
clamping time ranged from 42 to 56 minutes (mean, 48 
8 minutes), and the mean number of grafts was 3.6  0.5.
All data are presented as mean  standard deviation. None
of the enrolled patients had complications during the surgical
procedure or postsurgical follow-up.
Enhanced Expression of Urocortin mRNA and
Protein After Cardioplegic Arrest
To assess changes in gene expression of Ucn, we prepared
samples of mRNA from the myocardial biopsies and
quantified the change in Ucn mRNA by real-time PCR.
The results of this experiment, shown in Figure 1, A, docu-
mented a significant increase in Ucn RNA levels after cardi-
oplegic arrest (255% of basic levels, P< .05).
To extend this observation further, protein extracts were
also prepared from the cardiac biopsies andprobedwith a spe-
cific antibody to Ucn. As shown in Figure 1, B, a 4-fold in-
crease was observed in the protein abundance of Ucn in the
atrial specimens exposed to cardioplegic arrest (P< .05).
Thus, the results of 2 independent assays, involving either
mRNA quantification by real-time PCR or protein assessment
by Western blotting, confirmed a significant increase in Ucn
mRNA and protein levels in the postcardioplegic atrial biop-
sies, compared with the precardioplegic internal controls.
Induction and Activation of Protein Kinase Ce in
Postcardioplegic Atrial Biopsies
We then investigated whether the enhanced expression of
Ucn induced by cardioplegic arrest was associated with
TABLE 1. Operative details and clinical characteristics of enrolled
patients
Variables
No. 25
Female 11
Male 14
Age (y) 63  5
Aortic crossclamp (mean  SD, min) 48  8
Range (min) 42–56
Grafts 3.6  0.5
LV ejection fraction (% pre-CAGB) 54  1
LV ejection fraction (% post-CABG) 52  3
SD, Standard deviation; LV, left ventricular; CABG, coronary artery bypass grafting.
Data are expressed as mean  SD.1216 The Journal of Thoracic and Cardiovascular Suchanges in gene expression of PKCe. To this end, the
messenger RNA of PKCe was quantified by real-time
PCR. As shown in Figure 2, A, PKCe mRNA was signifi-
cantly induced in postcardioplegic cardiac specimens
(225% of internal control; P<.05). The increased transcrip-
tion of the PKCe gene paralleled a 2-fold overexpression of
total PKCe protein (P<.05), as assessed byWestern blotting
analysis (Figure 2, B).
To verify whether the induction of the protein levels of
total PKCe was also associated with enhanced functional
activation of this PKC isoform, protein extracts from atrial
samples collected before and after cardioplegia were probed
in a Western blot analysis with a specific antibody against
the phosphorylated active form of PKCe. This blot, shown
in Figure 2, B, documented a 2.9-fold increase in PKCe
phosphorylation (P<.01) in the cardiac specimens exposed
to cardioplegic arrest, compared with precardioplegic inter-
nal controls.
Thus, in hearts exposed to iIRI, Ucn induction at the
mRNA and protein level paralleled not only a selective
FIGURE 1. A, Quantitative PCR of Ucn mRNA levels in cardiac samples
collected before and after cardioplegic arrest. *P<.05 versus corresponding
precardioplegic internal controls. B, Expression of the Ucn protein, as deter-
mined by Western blotting of extracts from pre- and postcardioplegic atrial
tissues. Protein extracts were probed with a specific antibody to Ucn in
a 16% T, 6% C Tricine-SDS-PAGE system, complemented with 6 mol/L
urea. Marker proteins with the indicated molecular masses were also
used. Ucn, Urocortin.rgery c November 2009
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total PKCe isoform but also a 2.9-fold increase in PKCe
phosphorylation.
Mitochondrial Relocation of Activated Protein
Kinase Ce in Cardiac Myocytes Exposed to
Cardioplegic Arrest
To further advance our knowledge on PKCe-mediated
cardioprotection in the human heart undergoing iIRI, we
next explored whether the increased expression and activa-
tion of PKCe were observed concomitantly with enhanced
mitochondrial relocation. The results of this experiment
are illustrated in Figure 3. Total PKCe was primarily local-
ized in the cytosolic fraction before cardioplegia, whereas
FIGURE 2. A, Quantitative PCR of PKC-e mRNA levels from pre- and
postcardioplegic myocardial samples. *P < .05 versus corresponding
precardioplegic internal controls. B, Expression of total and phosphory-
lated PKCe protein, as determined by Western blotting of extracts from
human hearts before and after cardioplegic arrest. PKCe, Protein kinase Ce.The Journal of Thoracic and Caafter cardioplegic arrest, it was mainly detected in the mito-
chondrial fraction, indicating an active relocation of PKCe
from the cytosol to the mitochondrion in the human heart
undergoing iIRI (P< .05).
To produce supplementary information substantiating
these molecular findings, we next assessed the mitochondrial
relocation of activated PKCe by immunohistochemistry and
confocal microscopy. Numeric data and representative
images pertaining to this set of experiments are presented
in Table 2 and Figure 4, A and B, respectively. In the myo-
cardial specimens collected before cardioplegia, the intensity
of the immunostaining for phosphorylated PKCe was feeble
and detectable in a small fraction of cardiac cells (6.7% 
0.6%). In addition, in the group of cardiac cells showing
this faint, although visible, positive staining for phosphory-
lated PKCe, the proportion of PKCe/mitochondria colo-
calization was as low as 4.5%  1.4% (Figure 4, A, and
Table 2). Conversely, in the biopsies collected after cardio-
plegic arrest, a clear positive staining for active PKCe was
observed in more than one fifth of cardiac myocytes
(22.4% 3.4%; P<.05). In this selected myocyte subpop-
ulation, the colocalization of phosphorylated PKCe and
mitochondria was also dramatically increased, reaching
a percentage of 56%  8.3% (P< .01) (Figure 4, B, and
Table 2).
Thus, these results, in line with the molecular findings
obtained by means of subcellular fractionation, visually
FIGURE 3. Time course of mitochondrial translocation of PKCe in the hu-
man heart exposed to cardioplegic arrest as assessed by Western blotting in
protein extracts from cardiac samples collected before and after cardiople-
gia. Hsp60 and actin antibody have been used as specific markers of the mi-
tochondrial and cytosolic fractions, respectively. PKCe, Protein kinase Ce;
Hsp, heat shock protein.TABLE 2. Percentages of cardiac cells showing positive labeling for phosphorylated protein kinase Ce, urocortin, and TUNEL before and after
cardioplegic arrest
P-PKCeþmyocytes P-PKCe/mitochondria colocalization Urocortin TUNEL
Precardioplegia 6.7%  0.6% 4.5%  1.4% 1.5%  0.3% <0.1%
Postcardioplegia 22.4  3.4* 56%  8.3%y 24%  2.9%y 3.7%  0.6%*
P-PKCe, Phosphorylated protein kinase Ce; TUNEL, terminal deoxynucleotidyl transferase-mediated nick end labeling. The proportion of colocalization between P-PKCe and
mitochondria in cardiac myocytes exposed or unexposed to cardioplegia is also reported. Data in percent  SD are expressed as the means of 12 to 15 high-power fields.
*P< .05. yP< .01 versus corresponding precardioplegic samples.rdiovascular Surgery c Volume 138, Number 5 1217
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SFIGURE 4. Myocardial sections from atrial tissues collected before (A) and after (B) cardioplegic arrest. Cardiac sections were stained with primary anti-
body against the phosphorylated active form of PKCe and the mitochondria (Hsp60). Subsequently, the primary antibodies were labeled with secondary an-
tibody conjugated with fluorescein (green staining in the left panels) and rhodamine (red staining in the middle panels), respectively. Finally, myocardial
sections were counterstained with the nuclear labeling TOPRO-3 (blue staining in the right panels). Overlap of the 3 stainings is shown in the right panels
of both figures. The percentage of colocalization of phosphorylated PKCe and mitochondria was digitally quantified by means of image analyzer software.
Visually, overlap of ‘‘green’’ phosphorylated PKCe and ‘‘red’’ mitochondria gives rise to a bright orange fluorescent signal that can be observed in themerged
images presented in the right panels.confirmed and digitally quantified, at the cellular level, the
relocation of phosphorylated PKCe from the cytosolic to
the mitochondrial compartment in a considerable number
of cardiac cells exposed to cardioplegic arrest.
Selective Mitochondrial Relocation of Protein Kinase
C in Urocortin-Positive Myocytes Confers Protection
From Apoptosis
We next investigated whether myocytes showing mito-
chondrial relocation of PKCe were also expressing endoge-
nous Ucn and, if so, whether this combination was
associated with protection from apoptotic cell death. To es-
tablish this correlation, 3 adjacent 5-m myocardial sections,
serially cut from the same pre- and postcardioplegic wax
blocks, were immunostained either for phosphorylated
PKCe and mitochondria (Figure 5, A) or for Ucn (Figure 5,
B) or TUNEL labeling (Figure 5, C). The percentage data
referring to this set of experiments are reported in Table 2.
Cytosolic positive staining for Ucn was detected in 1.5%
 0.3% of cardiac cells before cardioplegia and in 24.6%
 2.9% of the myocytes population after cardioplegic arrest
(P<.01). Apoptotic cell death, assessed as nuclear TUNEL
positive labelling, was virtually absent in precardioplegic
samples (<0.01%) and observed in 3.7% 0.6% of themy-
ocyte population exposed to cardioplegic arrest (P<.05). Of
note, mitochondrial relocation of PKCewas only observed in1218 The Journal of Thoracic and Cardiovascular Supostcardioplegic cardiac cells with cytosolic positive stain-
ing for Ucn (Figure 5, A–C;P<.05). Furthermore, myocytes
exhibiting mitochondrial relocation of PKCe and cytosolic
positivity for Ucn staining at the same time were consistently
TUNEL negative (Figure 5, A–C; P< .05).
Thus, our findings show that concurrent overexpression
of Ucn and mitochondrial relocation of phosphorylated
PKCe can be detected only in viable myocytes and that
such combination is associated with protection of cardiac
cells from postcardioplegic apoptotic cell death.
Physical Interaction of Activated Protein Kinase Ce
With Kir6.1 After Cardioplegic Arrest
Having established that only cardiac cells overexpressing
Ucn and showing mitochondrial relocation of activated
PKCe are protected from apoptosis, we investigated themech-
anism by which active PKCe can afford cardioprotection
against apoptotic cell death, once relocated to the mitochon-
dria. We assumed that mitochondrial PKCe could physically
interact with 1 or more subunits forming the mitochondrial
KATP channel. To seek validation of our postulation, we pre-
pared additional protein extracts from tissue samples exposed
or unexposed to cardioplegic arrest. Phosphorylated PKCe
was enriched by immunoprecipitation using a specific anti-
body and immunoblotted with Kir6.1, Kir6.2, or SUR-2
antibody. As shown in Figure 6, a 1.8-fold increase wasrgery c November 2009
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same postcardioplegic wax block. The first section was stained with primary
antibody against phosphorylated PKCe and mitochondria (Hsp60) and
counterstained with TOPRO-3 (blue nuclear staining). Secondary antibody
conjugated with fluorescein or rhodamine were respectively used to label
phosphorylated PKCe and mitochondria. A, Overlap of the 3 stainings. B,
The second section was stained with a primary antibody against Ucn, sub-
sequently incubated with a secondary antibody conjugated with fluorescein,The Journal of Thoracic and Cobserved in the protein abundance of Kir6.1 in the
postcardioplegic samples, comparedwith the internal controls
(P< .05), whereas no increase was observed for Kir6.2 or
SUR-2. Furthermore, by immunoblotting with Kir6.1,
Kir6.2, and SUR-2, the immunoprecipitation of active PKCe
demonstrated that phosphorylated PKCe selectively interacts
with the Kir6.1 subunit (although not the Kir6.2 and SUR-2
subunits) of the mitochondrial KATP channels and that this
interaction is significantly enhanced by cardioplegic arrest
(P< .05). Thus, our findings suggest that in the human heart
exposed to cardioplegic arrest, active PKCe, onmitochondrial
relocation, physically interacts with the Kir6.1 subunit of the
mitochondrial KATP channel, and that this interaction is likely
to be involved in the protection of cardiac cells against apopto-
tic cell death.
DISCUSSION
Apoptotic cell death has been consistently implicated in
the pathogenesis of cardiac I/R injury, including the mild iat-
rogenic form associated with on-pump cardiac surgery.2-6
Among the several inhibitors of cardiac apoptosis reported
so far, Ucn, a 40-amino acid member of the corticotropin re-
leasing factor family,7 is especially motivating because it is
endogenously expressed in the human heart,22 together with
its cognate receptors.23
This report demonstrates that warm-blood cardioplegic
arrest and reperfusion given to an elective population rela-
tively comorbidity free induced enhanced expression of
Ucn, at both the mRNA and the protein levels. Although pre-
vious work from our group showed postcardioplegic induc-
tion of Ucn by means of immunohistochemistry,7 the actual
quantification of the Ucn protein by using aWestern blotting
approach had never been successful before, mainly because
of the technical challenge introduced by the small molecular
weight of the peptide.
In the same human heart exposed to cardioplegic arrest,
Ucn overexpression was associated with increased transcrip-
tion of the PKC-e gene, as well as induction of the PKC-e
protein. This novel isoform of the PKC protein family was
recently shown to play a pivotal role in the protection of
the heart against I/R injury and the mediation of ischemic
preconditioning.14,15 To exert its cardioprotective effects,
PKCe undergoes activation by phosphorylation followed
by relocation from the cytosol to the mitochondrial compart-
ment. The importance of these 2 sequential events was sub-
stantiated by a few experimental studies,24 but, to the best of
our knowledge, was never investigated in the clinical set-
ting. Our study shows that in the hearts of patients with
and finally counterstained with propidium iodide (red nuclear staining). C,
The third section was stained with TUNEL reagents and counterstained with
propidium iodide (red nuclear labeling). TUNEL-positive nuclei are stained
bright green.ardiovascular Surgery c Volume 138, Number 5 1219
Evolving Technology/Basic Science Chen-Scarabelli et al
E
T
/B
Sminimal comorbidities undergoing warm-blood cardiople-
gic arrest, the induction of PKCe, at both the mRNA and
the protein levels, paralleled enhanced activation and mito-
chondrial relocation of this PKC isoform. Cardiac myocytes
exhibiting at the same time mitochondrial relocation of
PKCe and cytosolic positive staining for Ucn were all viable,
being consistently TUNEL-negative. Overexpression of
Ucn together with PKCe relocation and cell survival have
been systematically observed in all low-risk patients of our
elective population (whose surgical procedure and postsur-
gical follow-up were uneventful) andmay represent the ideal
response of the human heart to cardioplegic arrest in the
absence of comorbidities. We are currently investigating
whether diversities in cardiac response to cardioplegia can
provide a molecular explanation for the poor postsurgical
outcomes observed in patients with comorbidities, such as
diabetes mellitus.
Recent studies have reported that exogenous Ucn can in-
duce activation and mitochondrial translocation of PKCe.15
In addition, pharmacologic inhibition of PKCe, or selective
knockout of its gene, was shown to abrogate Ucn-mediated
cardioprotection.15 Although intriguing, our data in the
postcardioplegic human heart are mainly conjectural and
cannot prove such a causative link among Ucn expression,
PKCe activation/relocation, and cell survival. To prove
that Ucn-mediated cardioprotection is dependent on PKCe
activation and mitochondrial translocation, a double-
blinded, randomized clinical trial evaluating the cardiopro-
tective effects of exogenous Ucn prophylactically infused
to patients undergoing cardioplegic arrest is currently under
way at the University of Verona, Italy.
FIGURE 6. Co-immunoprecipitation of phosphorylated PKCe with
Kir6.1, Kir6.2, and SUR-2 in protein extracts from pre- and postcardiople-
gic cardiac biopsies. Phosphorylated PKCewas enriched by immunoprecip-
itation using a specific antibody and immunoblotted with Kir6.1, Kir6.2, or
SUR-2 antibody. Input: protein extracts. PI, Pre–immune control antibody;
P-PKCe Ab, immunoprecipitation antibody against phosphorylated PKCe;
PKCe, protein kinase Ce.1220 The Journal of Thoracic and Cardiovascular SuSeveral pieces of evidence have also documented that
PKCe, once activated and translocated to the mitochondria,
can interact with different mitochondrial proteins.25,26 Once
again, this multitude of experimental data stand alone, being
unmatched in the human heart. We show that in patients un-
dergoing cardioplegic arrest, activated PKCe translocates to
the mitochondria, where it physically interacts with the
Kir6.1 subunit of the mitochondrial KATP channel. This in-
teraction is selective because it was not observed for the
other 2 components of the channels, represented by Kir6.2
and SUR-2. Because the cardioprotective effects of Ucn,
in the isolated cardiac cells and the intact heart, are
specifically blocked by both pharmacologic and genetic
inhibition of PKCe,15 as well as by generalized and mito-
chondrial-specific KATP channel blockers,
11 we may postu-
late that one mechanism of Ucn-mediated cardioprotection
involves induction and activation of PKCe, followed by
PKCe mitochondrial translocation and interaction with the
Kir6.1 subunit, finally resulting in opening of the mitochon-
drial KATP channel. Although the data we present in this
article do not enable mechanistic conclusions, similar con-
siderations on the mechanism of protection of Ucn may
also apply to the human heart exposed to iIRI.
CONCLUSIONS
We showed that cardioplegic arrest induces overexpres-
sion of endogenous Ucn, at both the mRNA and the protein
levels, in elective low-risk patients undergoing on-pump car-
diac surgery. This induction colocalized with PKCe activa-
tion, mitochondrial translocation, and myocyte survival
against apoptotic cell death. Because the loss and functional
impairment of myocytes after cardioplegic arrest are known
to directly reduce cardiac contractility, resulting in greater
mortality and morbidity associated with on-pump cardiac
surgery,3,4 interventions aimed at reducing the extent of
apoptotic cell death postoperatively are warranted. Among
the several strategies proposed, supplementation of cardio-
plegic solutions with exogenous Ucn seems to be promising
to reduce the risk of postsurgical cardiac dysfunction in
patients exposed to the inescapable I/R injury associated
with CABG.
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